Back to results
US 2026/0097104 A1Published application
Methods of Formulating a Vaccine
AssigneeMegaNano Biotech, Inc.
InventorChuanhai Cao
Life of this patent
Estimating the term…
Abstract
Disclosed herein are antigen sensitized exogenous immature dendritic cells. The dendritic cell may also be dead. Antigen sensitized dead exogenous immature dendritic cells may be used to elicit an immune response or reactivate the immune system. Further provided are vaccines comprising the dead antigen sensitized exogenous immature dendritic cells, methods of formulating vaccines, methods of inducing an immune response in a patient, and methods of treating a disease and methods of disease prevention.
Claims19
A method of formulating a vaccine, the method comprising obtaining an immature dendritic cell;
- contacting the immature dendritic cell with an antigen to form an antigen sensitized immature dendritic cell (DC), killing the antigen sensitized immature DC, to form a dead antigen sensitized immature DC, and formulating the vaccine comprising the dead antigen sensitized immature dendritic cell and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.